OLD Category: Oncology

The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population

• Wilson T.R. et al.,

Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer

• Shukuya T et al.,

Tumour sampling method can significantly influence gene expression profiles derived from neoadjuvant window studies

• Pearce D.A. et al.,

Global MicroRNA Profiling for Diagnostic Appraisal of Melanocytic Spitz Tumors

• Latchana N. et al.,

Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma express components of the renin-angiotensin system

• Itinteang T. et al.,

ADAR-mediated RNA editing predicts progression and prognosis of Gastric Cancer

• Chan M.H.N. et al.,

A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

• Yang S. et. al.,

Notch Signaling Activation is Associated with Patient Mortality and Increased FGF1-mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity

• Weaver A.N. et al.,

PBX3 is a putative biomarker of aggressive prostate cancer

• Ramberg H. et al.,

Gene Expression Profiling of Breast Cancer Brain Metastasis

• Lee J.Y. et al.,

Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors

• Donato E. et al.,

South African Breast Cancer and HIV Outcomes Study: Methods and Baseline Assessment

• Cubasch H. et al.,